English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Quanterix Licenses Multiplex SARS-CoV-2 Serology Test From Brigham and Women's
2020-05-12
Quanterix said on Monday it has inked a non-exclusive agreement with Brigham and Women's Hospital for a SARS-CoV-2 serology test on its Simoa multiplex immunoassay platform.
Genetic Ancestry Linked to Differences in Molecular Features of Cancers
2020-05-12
People of different ancestral backgrounds can have different DNA methylation, mRNA, and microRNA expression levels
Castle Biosciences Doubles Q1 Revenues
2020-05-12
Castle Biosciences reported after the close of the market on Monday that it doubles its first quarter revenues year over year.
10x Genomics Q1 Revenues Increase 34 Percent
2020-05-12
10x Genomics reported after the close of the market on Monday a 34 percent increase in first quarter revenues.
Pangolin Coronavirus Analysis Finds High Similarity to SARS-CoV-2
2020-05-12
Researchers have isolated a coronavirus from Malayan pangolins that is highly similar to SARS-CoV-2, suggesting pangolins may have served as an intermediate host for the virus.
Grifols ART System Nabs FDA Approval
2020-05-12
Grifols Diagnostic Solutions announced Thursday its Procelix Panther System featuring Automation Ready Technology (ART) received approval from the US Food and Drug Administration.
Guardant Health Q1 Revenues Up 84 Percent
2020-05-12
Guardant Health reported after the close of the market on Thursday that its first quarter 2019 revenues were up 84 percent year over year.
Grail Raises $390M in Series D Financing
2020-05-12
Grail said today that it has raised $390 million in a Series D financing round, which included new investors Public Sector Pension Investment Board, Canada Pension Plan Investment Board, and two other undisclosed contributors.
Amneal Pharmaceuticals Recalls Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL)
2020-04-22
The company is recalling three lots of Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) due to potential N-Nitrosodimethylamine (NDMA) contamination.
Avet Pharmaceuticals Recalls Tetracycline HCl Capsules USP, 250 mg and 500 mg
2020-04-22
The company is recalling Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles because of failed dissolution specifications.
Arch Venture Partners to Invest $1.46 Billion in Early Stage Biotechnology Companies
2020-04-22
Arch Venture Partners, an investment company headquartered in Chicago, IL, announced on April 2, 2020 that it closed two new funds
Alnylam Pharmaceuticals and Blackstone Life Sciences Enter into Collaboration for up to $2 Billion
2020-04-22
Alnylam Pharmaceuticals, an RNA interference (RNAi) therapeutics company located in Cambridge, MA, and Blackstone Life Sciences, a private investment platform
Maintaining GMPs During a Global Emergency
2020-04-22
The novel coronavirus pandemic has presented the global pharma industry with a double challenge: to develop potential treatments and preventative vaccines, and continue to meet the existing needs of healthcare providers and patients
BARDA Awards Moderna up to $483 Million for COVID-19 Vaccine Candidate Acceleration
2020-04-22
Moderna, a clinical stage biotechnology company headquartered in Cambridge, MA, announced on April 16, 2020 that the Biomedical Advanced Research and Development Authority (BARDA)
4D pharma to Launch Phase-II Study of Biotherapeutic Product for COVID-19 Treatment
2020-04-22
4D pharma to Launch Phase-II Study of Biotherapeutic Product for COVID-19 Treatment
Total:
3907
Pages:
261
First
Prev
1
..
211
212
213
214
215
216
217
..
261
Next
End
